Hybrid esophagectomy for oesophageal cancer: long-term results. A single-centre experience

par Lucie Hlaváčová, Radek Vrba, Čestmír Neoral, Rene Aujesky, Martin Stašek, Josef Chudáček, Katherine Vomáčková, David Vrána, Martin Sněhota
Publié 2020

Factors associated with higher rate of Complete Pathologic Response after Long-Course Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients – Results from a retrospecti...

par Carlos Cerdan-Santacruz, Laia Codina-Corrons, Mireia Merichal-Resina, Lucia Milla-Collado, Javier Trujillano-Cabello, Jordi Tarragona-Foradada, Nuria Mestres-Petit, Enrique Sierra-Grañón, Jorge Olsina-Kissler
Publié 2021

Radiation response of soft‐tissue extramedullary plasmacytoma in multiple myeloma—A case report

par Alexandra Gaube, Silvia Gabriela Nica, Camelia Dobrea, Stefania Ariana Neicu, Vanessa Gabriela Moldoveanu, Magda Serbanescu, Filip Stefan Calangiu
Publié 2021

Pathological Complete Response to Neoadjuvant Chemotherapy in a Patient with HER2-Positive Squamous Cell Carcinoma of the Breast

par Yuki Usui, Ryoichi Matsunuma, Kei Yamaguchi, Ryosuke Hayami, Aya Muramatsu, Makoto Suzuki, Michiko Tsuneizumi
Publié 2021

Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review

par Ana Julia Aguiar de Freitas, Rhafaela Lima Causin, Muriele Bertagna Varuzza, Cassio Murilo Trovo Hidalgo Filho, Vinicius Duval da Silva, Cristiano de Pádua Souza, Márcia Maria Chiquitelli Marques
Publié 2021

Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram

par Hao Cui, Dantong Zhao, Peng Han, Xudong Zhang, Wei Fan, Xiaoxuan Zuo, Panting Wang, Nana Hu, Hanqing Kong, Fuhui Peng, Ying Wang, Jiawei Tian, Lei Zhang
Publié 2021

Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data

par Jia-yi Li, Xuan-zhang Huang, Peng Gao, Yong-xi Song, Xiao-wan Chen, Xing-er Lv, Yv Fu, Qiong Xiao, Shi-yv Ye, Zhen-ning Wang
Publié 2021

Association of tumor‐infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer

par Jin Hong, Weiwei Rui, Xiaochun Fei, Xiaosong Chen, Kunwei Shen
Publié 2021

Pathological Complete Response of Clinical T4b Ascending Colon Cancer after Preoperative Chemotherapy Using Pembrolizumab

par Terufumi Yoshida, Hisanori Miki, Hironaga Satake, Toshinori Kobayashi, Yuuki Matsumi, Madoka Hamada, Shogen Boku, Nobuhiro Shibata, Mitsuaki Ishida, Mitsugu Sekimoto
Publié 2021

Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed...

par Antolín S, Acea B, Albaina L, Concha Á, Santiago P, García-Caballero T, Mosquera JJ, Varela JR, Soler R, Calvo L
Publié 2018

Durable Complete Response to Pembrolizumab in Esophageal Squamous Cell Carcinoma With Divergent Microsatellite Status: A Case Report

par Tian Zeng, Lei Zhang, Can Chen, Xiang Zhao, Xiaoqing Liu, Fengwei Ran, Tingting Yong, Ying Yang, Henghui Zhang, Henghui Zhang, Henghui Zhang, Yanling Zhang
Publié 2021

A single-nucleotide polymorphism of the beta 2-adrenergic receptor gene can predict pathological complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast...

par Du Y, Yan T, Zhou L, Yin W, Lu J
Publié 2018

Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials

par Yunhai Li, Lei Xing, Fan Li, Hong Liu, Lu Gan, Dejuan Yang, Mengxue Wang, Xuedong Yin, Hongyuan Li, Guosheng Ren, Guosheng Ren
Publié 2021

Omitting surgery in esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis

par Jaehyeon Park, Ji Woon Yea, Se An Oh, Jae Won Park
Publié 2021

Preoperative intensity-modulated chemoradiotherapy with simultaneous integrated boost in rectal cancer: five-year follow-up results of a phase II study

par But-Hadzic Jasna, Boltezar Anja Meden, Skerl Tina, Zadnik Vesna, Velenik Vaneja
Publié 2021